Richard L Littenberg

Title: The Innovative Contributions of Richard L. Littenberg

Introduction

Richard L. Littenberg is a notable inventor based in Kai Lua, Hawaii, who has made significant contributions to the field of immunogenic compositions. With a total of seven patents to his name, Littenberg's work focuses on developing treatments for conditions related to gastrin hormones, particularly in the context of ulcers and tumors.

Latest Patents

Among his latest patents, Littenberg has developed immunogenic compositions that target gastrin peptides. These compositions are designed for the treatment of ulcers or tumors that are influenced by gastrin hormones. The innovative aspect of these compositions lies in their ability to induce antibodies that selectively neutralize specific hormones. Additionally, he has disclosed pharmaceutical compositions that incorporate effective amounts of these immunogenic compositions, along with methods for treatment. Another significant patent involves a method for treating and preventing gastric and duodenal ulcers. This method operates by inducing antibodies that neutralize specific peptide gastric hormones, thereby limiting stomach acid secretion.

Career Highlights

Throughout his career, Richard L. Littenberg has worked with various companies, including Aphton Corporation and Philip C. Gevas. His experience in these organizations has contributed to his expertise in the development of pharmaceutical innovations.

Collaborations

Littenberg has collaborated with notable individuals in his field, including Philip C. Gevas and Stephen L. Karr. These collaborations have likely enhanced his research and development efforts.

Conclusion

Richard L. Littenberg's contributions to the field of immunogenic compositions demonstrate his commitment to advancing medical treatments for gastric-related conditions. His innovative patents reflect a deep understanding of the complexities of gastrin hormones and their impact on health.